We are live on ! Find out more
HCPC

Hamilton Capital Partners (Canada) Portfolio holdings

AUM $3.45B
1-Year Est. Return 58.23%
This Fund
S&P 500
This Quarter Est. Return
+12.71%
1 Year Est. Return
+58.23%
3 Year Est. Return
+142.85%
5 Year Est. Return
10 Year Est. Return
AUM
$2.42B
AUM Growth
+$456M
Cap. Flow
+$244M
Cap. Flow %
10.11%
Top 10 Hldgs %
31.94%
Holding
226
New
14
Increased
97
Reduced
67
Closed
9

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$30.9M
2
ADBE icon
Adobe
ADBE
+$26.7M
3
MA icon
Mastercard
MA
+$23.1M
4
COST icon
Costco
COST
+$22.3M
5
CRM icon
Salesforce
CRM
+$21.2M

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Materials 9.76%
3 Financials 9.63%
4 Energy 8.57%
5 Communication Services 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
76
Morgan Stanley
MS
$342B
$5.64M 0.23%
35,452
-6,096
-15% -$900K
MRSH
77
Marsh
MRSH
$89.6B
$5.59M 0.23%
27,727
+4,537
+20% +$933K
SCHW
78
Charles Schwab
SCHW
$192B
$5.55M 0.23%
58,092
-2,843
-5% -$270K
COF icon
79
Capital One
COF
$139B
$5.49M 0.23%
+25,817
New +$5.65M
AXP icon
80
American Express
AXP
$231B
$5.28M 0.22%
15,902
-1,740
-10% -$553K
KKR icon
81
KKR & Co
KKR
$102B
$5.28M 0.22%
40,629
+37,179
+1,078% +$5.28M
MCK icon
82
McKesson
MCK
$101B
$5.21M 0.22%
+6,747
New +$4.75M
BX icon
83
Blackstone
BX
$108B
$5.21M 0.22%
30,470
-5,973
-16% -$1.02M
DHR icon
84
Danaher
DHR
$142B
$5.06M 0.21%
25,542
+2,439
+11% +$485K
MRK icon
85
Merck
MRK
$335B
$5.03M 0.21%
59,906
+5,477
+10% +$451K
PFE icon
86
Pfizer
PFE
$153B
$5M 0.21%
196,120
+4,827
+3% +$119K
ABBV icon
87
AbbVie
ABBV
$441B
$4.89M 0.2%
21,140
-3,218
-13% -$655K
AMGN icon
88
Amgen
AMGN
$225B
$4.88M 0.2%
17,285
+1,697
+11% +$492K
BMY icon
89
Bristol-Myers Squibb
BMY
$130B
$4.84M 0.2%
107,333
+22,658
+27% +$1.06M
VRTX icon
90
Vertex Pharmaceuticals
VRTX
$128B
$4.83M 0.2%
12,329
+2,813
+30% +$1.18M
TMO icon
91
Thermo Fisher Scientific
TMO
$218B
$4.82M 0.2%
9,940
+124
+1% +$57.7K
UNH icon
92
UnitedHealth
UNH
$361B
$4.78M 0.2%
13,832
-43,044
-76% -$13M
ISRG icon
93
Intuitive Surgical
ISRG
$139B
$4.76M 0.2%
10,653
+1,748
+20% +$839K
BSX icon
94
Boston Scientific
BSX
$75.1B
$4.76M 0.2%
48,794
+1,095
+2% +$113K
CI icon
95
Cigna
CI
$74.7B
$4.71M 0.19%
16,332
+1,435
+10% +$425K
GILD icon
96
Gilead Sciences
GILD
$172B
$4.66M 0.19%
41,941
-3,110
-7% -$353K
ABT icon
97
Abbott
ABT
$193B
$4.62M 0.19%
34,501
-2,796
-7% -$367K
SYK icon
98
Stryker
SYK
$130B
$4.6M 0.19%
12,452
-585
-4% -$226K
CVS icon
99
CVS Health
CVS
$124B
$4.58M 0.19%
60,812
+2,198
+4% +$151K
WELL icon
100
Welltower
WELL
$170B
$4.28M 0.18%
23,998
+3,193
+15% +$525K

Similar funds

Hamilton Capital Partners (Canada)'s Q3 2025 Portfolio in Review

As of Q3 2025, Hamilton Capital Partners (Canada) held 226 positions worth $2.42B, up 23% from $1.96B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Hamilton Capital Partners (Canada) deployed $244M of net new capital in Q3 2025, opening 14 new positions and adding to 97 existing holdings. Its largest new stake was State Street Technology Select Sector SPDR ETF: 700,724 shares worth $98.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 27% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was Mastercard, an estimated $23.1M trimmed.

  • Hamilton Capital Partners (Canada)'s largest Q3 2025 buy was State Street Technology Select Sector SPDR ETF: 700,724 shares worth $98.8M.
  • Hamilton Capital Partners (Canada) added most to Vanguard S&P 500 ETF in Q3 2025, an estimated $53.3M increase.
  • Hamilton Capital Partners (Canada)'s biggest Q3 2025 reduction was Mastercard, cutting an estimated $23.1M.
  • Hamilton Capital Partners (Canada) fully exited Texas Instruments in Q3 2025, selling an estimated $30.9M.
  • Hamilton Capital Partners (Canada)'s ten largest holdings make up 32% of its $2.42B portfolio in Q3 2025.
  • Hamilton Capital Partners (Canada) opened 14 new positions and closed 9 in Q3 2025.
  • Hamilton Capital Partners (Canada)'s portfolio value rose 23% quarter-over-quarter to $2.42B.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q3 2025, filed 14 Aug 2026.